• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
The Effect of Trigger Point Injections on Pain in Patients with Advanced Cancer.触发点注射对晚期癌症患者疼痛的影响。
Korean J Fam Med. 2019 Sep;40(5):344-347. doi: 10.4082/kjfm.18.0065. Epub 2019 Sep 6.
2
A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds.一项随机对照研究，比较利多卡因贴片、安慰剂贴片和麻醉注射治疗肌筋膜疼痛综合征患者触发点的效果：疼痛和躯体痛阈值评估
Clin Ther. 2009 Apr;31(4):705-20. doi: 10.1016/j.clinthera.2009.04.006.
3
Does kinesiotaping increase the efficacy of lidocaine injection in myofascial pain syndrome treatment? A randomized controlled study.肌内效贴布能否提高利多卡因注射治疗肌筋膜疼痛综合征的疗效？一项随机对照研究。
J Back Musculoskelet Rehabil. 2019;32(3):471-477. doi: 10.3233/BMR-171035.
4
A Comparative Pilot Study to Evaluate the Adjunctive Role of Levosulpride with Trigger Point Injection Therapy in the Management of Myofascial Pain Syndrome of Orofacial Region.一项比较性初步研究：评估左舒必利辅助触发点注射疗法在治疗口面部区域肌筋膜疼痛综合征中的作用
J Maxillofac Oral Surg. 2014 Dec;13(4):599-602. doi: 10.1007/s12663-013-0548-x. Epub 2013 Jun 6.
5
Efficacy and Safety of Single Botulinum Toxin Type A (Botox®) Injection for Relief of Upper Trapezius Myofascial Trigger Point: A Randomized, Double-Blind, Placebo-Controlled Study.A型肉毒毒素（保妥适®）单次注射缓解上斜方肌肌筋膜触发点的疗效与安全性：一项随机、双盲、安慰剂对照研究。
J Med Assoc Thai. 2015 Dec;98(12):1231-6.
6
Ultrasound-guided trigger point injections in the cervicothoracic musculature: a new and unreported technique.超声引导下颈胸肌触发点注射：一种新的未报道技术。
Pain Physician. 2008 Nov-Dec;11(6):885-9.
7
Comparison of 3 needle sizes for trigger point injection in myofascial pain syndrome of upper- and middle-trapezius muscle: a randomized controlled trial.三种针头尺寸用于上斜方肌和中斜方肌肌筋膜疼痛综合征触发点注射的比较：一项随机对照试验
Arch Phys Med Rehabil. 2009 Aug;90(8):1332-9. doi: 10.1016/j.apmr.2009.01.028.
8
Evaluation of the effects of occlusal splint, trigger point injection and arthrocentesis in the treatment of internal derangement patients with myofascial pain disorders.评价咬合夹板、触发点注射和关节穿刺术治疗伴有肌筋膜疼痛紊乱的关节内紊乱患者的效果。
J Craniomaxillofac Surg. 2018 Jun;46(6):916-922. doi: 10.1016/j.jcms.2018.03.018. Epub 2018 Mar 31.
9
Acupuncture Combined with Trigger Point Injection in Patient with Chronic Myofascial and Referred Pain.针刺联合触发点注射治疗慢性肌筋膜及牵涉痛患者
Bull Tokyo Dent Coll. 2020 Jul 4;61(2):121-126. doi: 10.2209/tdcpublication.2019-0017. Epub 2020 Jun 5.
10
Characteristics of Myofascial Pain Syndrome of the Infraspinatus Muscle.冈下肌肌筋膜疼痛综合征的特征
Ann Rehabil Med. 2017 Aug;41(4):573-581. doi: 10.5535/arm.2017.41.4.573. Epub 2017 Aug 31.

引用本文的文献

1
Development of evidence-based indicators for the detection of drug-related problems among ovarian cancer patients.制定用于检测卵巢癌患者药物相关问题的循证指标。
Front Pharmacol. 2023 Jun 30;14:1203648. doi: 10.3389/fphar.2023.1203648. eCollection 2023.
2
Preliminary evidence of safety and effectiveness of Loxoprofen Sodium Cataplasm combined with physiotherapy for myofascial pain syndrome treatment: A randomized controlled pilot clinical trial.洛索洛芬钠巴布剂联合物理治疗对肌筋膜疼痛综合征治疗的安全性和有效性的初步证据：一项随机对照试验性临床试验
Front Neurol. 2022 Nov 22;13:998327. doi: 10.3389/fneur.2022.998327. eCollection 2022.
3
Interventional Therapies for Pain in Cancer Patients: a Narrative Review.癌症患者疼痛的介入治疗：一项叙述性综述
Curr Pain Headache Rep. 2021 May 7;25(7):44. doi: 10.1007/s11916-021-00963-2.
4
The Case for Comorbid Myofascial Pain-A Qualitative Review.共病性肌筋膜疼痛的案例研究：定性综述。
Int J Environ Res Public Health. 2020 Jul 17;17(14):5188. doi: 10.3390/ijerph17145188.

本文引用的文献

1
Myofacial Trigger Points in Advanced Cancer Patients.晚期癌症患者的肌筋膜触发点
Indian J Palliat Care. 2016 Jan-Mar;22(1):80-4. doi: 10.4103/0973-1075.173956.
2
Myofascial pain syndrome after head and neck cancer treatment: Prevalence, risk factors, and influence on quality of life.头颈癌治疗后的肌筋膜疼痛综合征：患病率、危险因素及对生活质量的影响。
Head Neck. 2015 Dec;37(12):1733-7. doi: 10.1002/hed.23825. Epub 2014 Sep 25.
3
[Trigger point therapy for myofascial pain in cancer patients (first report)-analysis results of special use-results surveillance by Neovitacain® injection-].[癌症患者肌筋膜疼痛的触发点疗法（首次报告）——特殊用途的分析结果——通过新维他卡因®注射进行结果监测——]
Gan To Kagaku Ryoho. 2011 Oct;38(10):1659-65.
4
Trigger point injections for chronic non-malignant musculoskeletal pain: a systematic review.慢性非恶性肌肉骨骼疼痛的触发点注射：一项系统评价
Pain Med. 2009 Jan;10(1):54-69. doi: 10.1111/j.1526-4637.2008.00526.x. Epub 2008 Nov 5.
5
The use of "as-needed" range orders for opioid analgesics in the management of acute pain: a consensus statement of the American Society for Pain Management Nursing and the American Pain Society.阿片类镇痛药“按需”剂量医嘱在急性疼痛管理中的应用：美国疼痛管理护理学会和美国疼痛学会的共识声明
Pain Manag Nurs. 2004 Jun;5(2):53-8. doi: 10.1016/j.pmn.2004.04.001.
6
Botulinum toxin therapy for myofascial pain disorders.肉毒毒素治疗肌筋膜疼痛障碍
Curr Pain Headache Rep. 2002 Oct;6(5):355-60. doi: 10.1007/s11916-002-0076-8.
7
Pain in far-advanced cancer.晚期癌症疼痛。
Pain. 1982 Nov;14(3):303-310. doi: 10.1016/0304-3959(82)90137-3.

触发点注射对晚期癌症患者疼痛的影响。

The Effect of Trigger Point Injections on Pain in Patients with Advanced Cancer.

作者信息

Lee Chang Yub, Kim Eeun Jung, Hwang Dae Geun, Jung Moon Yong, Cho Hyun Geun

机构信息

Department of Family Medicine, Busan Bohun Veterans, Busan, Korea.

出版信息

Korean J Fam Med. 2019 Sep;40(5):344-347. doi: 10.4082/kjfm.18.0065. Epub 2019 Sep 6.

DOI:10.4082/kjfm.18.0065
PMID:31487973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6768837/
Abstract

BACKGROUND

It has been reported that in 62.5% of cases of incurable cancer pain, the complaint is due to myofascial pain syndrome. Trigger point injections using dibucaine hydrochloride help patients with such cancer pain. This study evaluated the efficacy of trigger point injections for alleviating pain in patients with advanced cancer.

METHODS

Twenty patients with advanced cancer who had a life expectancy of 6 months or less and had been diagnosed with myofascial pain syndrome were treated with trigger point injections. Prior to treatment, a Visual Analog Scale (VAS) was used to measure the resting pain level and discomfort upon application of pressure on the site of pain. These values were compared with last treatment measurements.

RESULTS

The mean pre-treatment VAS scores for pain at rest and upon application of pressure on the pain site were 7.3 and 9.0, respectively. These scores decreased significantly to 1.95 and 3.2, respectively, after the treatment (P<0.05).

CONCLUSION

Trigger point injection is an alternative and effective pain control modality for advanced cancer patients with myofascial pain syndrome.

摘要

背景

据报道，在62.5%的无法治愈的癌症疼痛病例中，主诉是由于肌筋膜疼痛综合征。使用盐酸丁卡因进行触发点注射有助于缓解此类癌症疼痛患者的症状。本研究评估了触发点注射对缓解晚期癌症患者疼痛的疗效。

方法

对20例预期寿命6个月或更短且已被诊断为肌筋膜疼痛综合征的晚期癌症患者进行触发点注射治疗。治疗前，使用视觉模拟量表（VAS）测量静息时的疼痛水平以及在疼痛部位施加压力时的不适程度。将这些值与最后一次治疗测量值进行比较。

结果

静息时疼痛和在疼痛部位施加压力时的治疗前VAS平均评分分别为7.3和9.0。治疗后，这些评分显著降至1.95和3.2（P<0.05）。

结论

触发点注射是晚期癌症合并肌筋膜疼痛综合征患者的一种替代且有效的疼痛控制方式。